Tag #Humira

Showing 1 to 2 of 2 results

telegraaf.nl
🌐 85% Global Worthiness
News related image

Lawsuit Challenges AbbVie's Humira Pricing, Highlighting Drug Cost Debate

A Dutch foundation is suing AbbVie for excessive profits from Humira, arguing its high price displaced other healthcare needs; AbbVie counters that high prices are needed to cover development costs, and the patent expiry in 2018 caused prices to plummet by nearly 90% by 2023.

Progress

60% Bias Score

Good Health and Well-being
nrc.nl
🌐 85% Global Worthiness
News related image

Dutch Court to Rule on AbbVie's Humira Pricing Lawsuit

A Dutch court will rule on a lawsuit against AbbVie for allegedly making €1 billion in excessive profits from its rheumatoid arthritis drug Humira (adalimumab) between 2004 and 2018; the foundation Farma ter Verantwoording claims this money could have improved the health of 14,000 people.

Progress

52% Bias Score

Reduced Inequality

Showing 1 to 2 of 2 results